- 질문내용 -
No, I'm not particularly sporty apotheke apcalis The cellular therapy company said it received a grant of$147,765 from the National Institutes of Health to fundpreclinical studies testing the potential of its stem celltechnology to treat wounds associated with scleroderma. NeoStemsaid it may qualify for an additional $1.5 million grant basedon the results of the study. Scleroderma is a tissue diseasethat causes the skin and connective tissues to harden andtighten.
|
|
